Cara DeGette, Rocky Mountain Post

Skyrocketing drug prices have inspired lawmakers in 11 states, including Colorado, to introduce legislation requiring pharmaceutical companies to detail how much it costs to research, develop and produce drugs.

Colorado’s HB 1102, introduced last month, would apply to pharmaceuticals that are priced at more than $50,000 per year or per course of treatment.

Supporting groups include the National Federation of Independent Business and Service Employees International Union, as well as such diverse organizations as Healthy Colorado and the Colorado Consumer Health Initiative. 

Read the full article here

Translate »